XOMA Royalty (XOMA) Gains from Investment Securities (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Gains from Investment Securities came in at $2.1 million in Q1 2026, up 430.04% year-on-year from $400000.0 in Q1 2025, and down 21.74% quarter-over-quarter from $2.7 million in Q4 2025.

XOMA Royalty (XOMA) Gains from Investment Securities (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Gains from Investment Securities across 17 years of filings, most recently posting $2.1 million for Q1 2026.

  • Gains from Investment Securities for Q1 2026 came in at $2.1 million, up 430.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.1 million (up 227.03% YoY), and the FY2025 annual result was $2.2 million, down 11.27% from the prior year.
  • Gains from Investment Securities came in at $2.1 million for Q1 2026 at XOMA Royalty, down from $2.7 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $2.7 million in Q4 2025 to a low of -$2.6 million in Q4 2024.
  • The 5-year median for Gains from Investment Securities is $180000.0 (2023), against an average of $474367.4.
  • Across the five-year window, Gains from Investment Securities soared 1300.33% in 2022 and tumbled 678.67% in 2024, its largest moves.
  • XOMA Royalty's Gains from Investment Securities stood at -$1.4 million in 2022, then jumped by 132.1% to $450000.0 in 2023, then sank by 678.67% to -$2.6 million in 2024, then surged by 204.03% to $2.7 million in 2025, then fell by 21.74% to $2.1 million in 2026.
  • The last three Gains from Investment Securities figures came in at $2.1 million (Q1 2026), $2.7 million (Q4 2025), and $9936.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn -
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn -
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn -
6 Evaxion A 1,551.28 Bn 1,551.26 Bn -
7 Psyence Biomedical 227.32 Bn 227.31 Bn -
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn
9 Abivax 91.71 Bn 91.71 Bn -
10 XOMA Royalty 5.48 Mn -60.60 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.12 Mn
Mar 31, 2026 2.12 Mn
Dec 31, 2025 2.71 Mn
Dec 31, 2025 2.71 Mn
Sep 30, 2025 9,936.00
Sep 30, 2025 9,936.00
Jun 30, 2025 9,936.00
Jun 30, 2025 9,936.00
Mar 31, 2025 400,000.00
Mar 31, 2025 400,000.00
Dec 31, 2024 -2.60 Mn
Dec 31, 2024 -2.60 Mn
Sep 30, 2024 2.48 Mn
Sep 30, 2024 2.48 Mn
Jun 30, 2024 34,170.00
Jun 30, 2024 34,170.00
Mar 31, 2024 275,000.00
Mar 31, 2024 275,000.00
Dec 31, 2023 450,000.00
Dec 31, 2023 450,000.00